Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07231588 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation

StatusRecruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 5, 2026 (before its estimated June 29, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status: Not Yet Recruiting to Recruiting Primary completion date: Jun 1, 2026 to Jun 29, 2026 · Completion date: Dec 1, 2026 to Dec 29, 2026 · Start date changed from estimate of Dec 1, 2025 to Jan 29, 2026 · 1 morev2 Show 4 more changesShow less
    • Primary completion date: Jun 1, 2026 to Jun 29, 2026
    • Completion date: Dec 1, 2026 to Dec 29, 2026
    • Start date changed from estimate of Dec 1, 2025 to Jan 29, 2026
    • Site details revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This research is to determine if an oral probiotic, Pendulum Glucose Control (PGC), can be safely given to patients during pelvic radiation therapy (RT). The researchers will study if the probiotics lessen gastrointestinal toxicity during pelvic radiation.
Trial Details
NCT Number NCT07231588
Lead Sponsor University of Cincinnati
Collaborators: Pendulum Therapeutics
Conditions Radiation Injuries
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov